Research Papers

25 of 1549 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Clinical Characteristics and Molecular Epidemiology of ST23 <i>Klebsiella pneumoniae</i> in China.
Liu Y; Jian Z; Wang Z; Yang A; Liu P; Tang B; Wang J; Yan Q; Liu W.
Infect Drug Resist (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Exploring and Predicting the Drivers of Ongoing HIV-1 Transmission in Guangyuan, Sichuan.
Zhang Y; Jiang H; Xiang W; Zhu J; Hou X; Liang S; Yuan D; Zhou C; Su L.
Infect Drug Resist (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Potential Causes of Spread of Antimicrobial Resistance and Preventive Measures in One Health Perspective-A Review.
Endale H; Mathewos M; Abdeta D.
Infect Drug Resist (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Similarities and Differences Between Diabetes-Related and Trauma-Related Calcaneal Osteomyelitis: Comparisons Based on …
Liu GQ; Chen P; Huang MZ; Song MR; Song CS; Zhu RJ; Xiong J; Jiang N; Yu B.
Infect Drug Resist (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Surveillance and Outcomes of Pediatric Hematopoietic Stem Cell Transplantation Recipients During the Recent COVID-19 Ou…
Wang X; Yu U; Ding C; Ye H; Wang C; Yang C; Li Y; Zhou X; Zhang Q; Liu S; Wen F.
Infect Drug Resist (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Analysis of Risk Factors for Carbapenem Resistant <i>Klebsiella pneumoniae</i> Infection and Construction of Nomogram M…
Wardoyo S; Slamet S; Hanif MI; Anwar T.
Infect Drug Resist (Unknown)
Published: 2023
2/6 Transparent
Antibiotic Resistance and Epidemiology of <i>Vibrio parahaemolyticus</i> from Clinical Samples in Nantong, China, 2018-…
Huang A; Wang Y; Xu H; Jin X; Yan B; Zhang W.
Infect Drug Resist (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Prognostic Value of Wagner Grade and Platelet Level in Diabetics with Infected Foot Ulcers After Antibiotic Therapy.
Yang X; Yan T; Shen D; Sheng M; Huang W; Li L; Chai D.
Infect Drug Resist (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Analysis of Risk Factors for Carbapenem Resistant <i>Klebsiella pneumoniae</i> Infection and Construction of Nomogram M…
Wang H; Tian F; Wang X; Zhao M; Gao R; Cui X.
Infect Drug Resist (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The Efficacy and Safety of Shashen-Maidong Decoction Combined with Western Medicine in the Treatment of Omicron Infecte…
Lin XX; Yin YQ; Zhang WZ; Huang JH; Hu WS.
Infect Drug Resist (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Fractional Dosing of Yellow Fever Live Attenuated 17D Vaccine: A Perspective.
Hansen CA; Staples JE; Barrett ADT.
Infect Drug Resist (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Clinical Efficacy and Safety Evaluation of Ceftazidime-Avibactam in the Treatment of <i>Klebsiella pneumoniae</i> Infec…
Xu J; Luo C; Huang L; Xiao X; Liu L; Yang Z.
Infect Drug Resist (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Clinical Efficacy of Ulinastatin Combined with Azithromycin in the Treatment of Severe Pneumonia in Children and the Ef…
Dian D; Zhang W; Lu M; Zhong Y; Huang Y; Chen G; Chen Z; Yu L; Sun J.
Infect Drug Resist (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Potentiation and Mechanism of Berberine as an Antibiotic Adjuvant Against Multidrug-Resistant Bacteria.
Zhou H; Wang W; Cai L; Yang T.
Infect Drug Resist (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Asymptomatic Malaria During Pregnancy: Prevalence, Influence on Anemia and Associated Factors in West Guji Zone, Ethiop…
Sriwahyuni S; Farisni TN; Nugroho HSW.
Infect Drug Resist (Unknown)
Published: 2023
2/6 Transparent
Molecular Epidemiology of Carbapenem Resistant <i>Klebsiella Pneumoniae</i> in Northern China: Clinical Characteristics…
Cai W; Kang J; Ma Y; Yin D; Song Y; Liu Y; Duan J.
Infect Drug Resist (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Risk Factors, Outcomes, and Predictions of Extensively Drug-Resistant <i>Acinetobacter baumannii</i> Nosocomial Infecti…
Huang L; Tang J; Tian G; Tao H; Li Z.
Infect Drug Resist (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Impact of Irrational Use of Antibiotics Among Patients in the Intensive Care Unit on Clinical Outcomes in Sudan.
Abdelkarim OA; Abubakar U; Taha LO; Ashour SA; Abass WY; Osman EM; Muslih MS.
Infect Drug Resist (Unknown)
Published: 2023
2/6 Transparent
New Attempts to Inhibit Methicillin-Resistant <i>Staphylococcus aureus</i> Biofilm? A Combination of Daptomycin and Azi…
Zhou Y; Liu MJ; Liao XY; Chen YT; Liao QX; Lin JD; Lin HR; Huang YH.
Infect Drug Resist (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Analysis of the Sputum Culture Spectrum of Children with Respiratory Tract Infection in Wuxi Between 2014 and 2021.
Jia HL; Gao J; Ren F; Ma Y.
Infect Drug Resist (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Clinical Characteristics Associated with Poor Prognosis of Acquired Immunodeficiency Syndrome Patients Complicated with…
Wu L; Pan Y; Xu K.
Infect Drug Resist (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Identification of Significant Pathogenic Nontuberculous Mycobacteria Species from Presumptive TB Patients Using Partial…
Pascapurnama DN; Zavitri NG; Koesoemadinata RC; Cahyadi AI; Chaidir L.
Infect Drug Resist (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Study on Respiratory Function and Hemodynamics of AIDS Patients with Respiratory Failure.
Qiu K; Lu J; Guo H; Du C; Liu J; Li A.
Infect Drug Resist (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Bedaquiline Resistance and Molecular Characterization of Rifampicin-Resistant <i>Mycobacterium Tuberculosis</i> Isolate…
Tong E; Zhou Y; Liu Z; Zhu Y; Zhang M; Wu K; Pan J; Jiang J.
Infect Drug Resist (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The Biological and Regulatory Role of Type VI Secretion System of <i>Klebsiella pneumoniae</i>.
Liu W; Li M; Cao S; Ishaq HM; Zhao H; Yang F; Liu L.
Infect Drug Resist (Unknown)
Published: 2023
3/6 Transparent
Funding Declared